Both in Pharmaceuticals
Immuneering vs Korro Bio
Over the past year IMRX returned −42.2% and KRRO returned −54.3%; their daily moves had a correlation of 0.10.
IMRX −42.2% KRRO −54.3%Growth of $1, one year, split-adjusted
| Metric | IMRX | KRRO |
|---|---|---|
| Price | $3.79 | $16.82 |
| Market cap | $245.5M | $247.7M |
| Today | +2.99% | +6.05% |
| 1 month | −1.0% | +72.3% |
| 6 months | −27.0% | +26.1% |
| Year to date | −42.4% | +110.0% |
| 1 year | −42.2% | −54.3% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 104.0× |
| Net cash | $145.4M | $115.0M |
| Dividend yield | — | — |
| Volatility (60d) | 52.7% | 96.3% |
| Short % of float | 29.2% | 14.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).